A pair of Canadian biotechnology venture capital firms have launched new programs to arm academics with entrepreneurial skills in an effort to help fix a chronic talent gap in the country’s burgeoning life sciences sector. The programs, by Lumira Ventures and Amplitude Venture Capital, join a growing mass of Canadian initiatives aiming to expand the shallow pool of domestic executives who can grow early-stage therapeutic developers beyond the startup stage into billion-dollar companies.
